21
Apr
Lycotec quest to target the deadliest of crystals
Lycotec Ltd, a biotech company based in Cambridge UK, is raising funds to undertake a phase II clinical trial which would target cholesterol crystals. These crystals are one of the main causes of the rupture of atherosclerotic plaques. After breaking the cap of a vulnerable plaque, the crystals protrude into the lumen of coronary or […]
Read more
Categories
Recent posts
-
Lycotec presents at the American Heart Association’s Scientific Sessions4th November 2021
-
Lycotec CEO, Dr Ivan Petyaev to attend The Future Food-Tech Summit9th October 2019
Newsletter
Subscribe to our weekly newsletter now. Enter your email and name and click subscribe
Recent Tweets
-
We love seeing what our talented community creates 💚 Like 'Pandora', which @gv_visuals and @pmw_psd designed with a… https://t.co/QFTBGlM4ss
1 hour ago -
Need some help getting cut-through on social media? 🧐 These expert tips on how to create a killer social media st… https://t.co/rXQ7PzI3JC
1 day ago -
Do you often feel like you need a translator to help explain your visual ideas? 📖 Articulate them with ease, using… https://t.co/he0VYLUISS
2 days ago
Recent Comments